OBJECTIVE -to analyses the results of patients' surgery, to determine the incidence rate of surgical site infections (SSIs) and to identify prevailing pathogens and their resistance to antibiotics in Ukrainian hospitals.
INTRODUCTION
Despite major advances in infection control interventions, health care-associated infections (HAI) remain a major public health problem and patient safety threat worldwide [1, 2] . The global estimated prevalence of HAI, at any given time, approximates 1.4 million [3] . Surgical site infections (SSIs) are the most common type of nosocomial infection among surgical patients. [4] [5] [6] [7] . SSIs is a wound infection that occurs following an invasive procedure. SSIs accounts for over 20 % of all healthcare-associated infections in surgical patients [4] . According to the state statistical reports, SSIs are the most frequent post-surgical complications in Ukraine with incidences from 3 % to 35 % [6, [8] [9] [10] . SSIs are defined as infections occurring up to 30 days after surgical procedures (or up to one year after surgery in patients receiving implants) and affecting either the incision or deep tissue at the operation site. Despite improvements in prevention, SSIs remain a significant clinical problem as they are associated with substantial mortality and morbidity and impose severe demands on healthcare resources. SSIs are infections of the incision or organ or space that occur after surgery [11] . Surgical patients initially seen with more complex comorbidities [12] and the emergence of antimicrobial-resistant pathogens increase the cost and challenge of treating SSIs [13] . SSIs is unequivocally morbid and costly. It has been reported that more than one-third of postoperative deaths worldwide are related to SSIs [14] . It has been estimated 300,000 SSIs annually in the United States represent the second most common infection among surgical patients, prolong hospitalization by 7-10 days, and have an estimated annual incremental cost of $1 billion [15] . Several studies have estimated that the burdens that hospitals or national health trusts face increases in costs ranging from £814 to £6,626 ($1,341-10,922) per patient in England, depending on the type of surgery involved and the severity of infection [16] . Other studies have reported an average cost of €325 ($4,544) per day in Europe and $25,546 per infection in the United States [17, 18] . The hospital-related cost of a single SSIs in the United States has been estimated at $12,000-$35,000 [19] , and estimates of annual nationwide hospital costs of SSIs have ranged from $3 billion to $10 billion [20] . Costs can exceed $90,000 per infection when the SSIs involves a prosthetic joint implant [21] or an antimicrobialresistant organism [22] . Challenges related to the prophylaxis and therapy of post-surgical pyoinflammatory infections are extremely relevant. One of the reasons for SSIs is the wide spread of conditionally pathogenic microorganisms (CPM) that are resistant to anti microbial medicines and cause nosocomial infec tions [6, 13, 22] . Every year resistant nosocomial infections are becoming more and more pressing for medical specialists in Ukraine. Current guidelines for the treatment of infections recommend the immediate prescription of antimicrobial medicines as soon as the infection is diagnosed. Broad spectrum antimicrobials should be prescribed even before the culture results are known in order to cure the most probable infection agents. Targeted antibacterial treatment should be provided following the identification of an etiological agent and resistance status. However, the results of numerous investigations prove that the prescription of an inadequate starting therapy raises the mortality rate among patients with severe infections by 1.5-3.0 times [14, 15] . In addition, inadequare therapy extends the duration of hospitalization and provokes a need for additional courses of antimicrobial therapy that makes treatment more expensive [16] [17] [18] [19] [20] [21] [22] . Surveillance, which records infection prospectively and actively, is an essential method for understanding the incidence and distribution of healthcare-associated infections. Site-oriented target surveillance, which is usually undertaken for selected high-risk infections and specialties, provides more accurate data. However, surveillance in Ukraine remains inadequate and inaccurate [6, [8] [9] [10] . In Ukraine, public reports of SSIs, obtained via ongoing national surveillance activities, have been rare over the past decades. However, many articles have reported that SSIs surveillance at hospital level varies widely. Epidemiological control in surgical hospitals is provided through continuous microbiological monitoring to reveal, identify and register various infections, their symptoms, development tendencies and sensitivity to antimicrobial medicines. This data provides a foundation for developing a strategy for the use of antibio tics in surgery hospitals. The microbiological diagnostics of infections (identification of pathogens and sensitivity to antibiotics) is necessary for optimal antimicrobial therapy. However, data on the etiology and resistance of pathogens associated with nosocomial infections in surgical hospitals varies considerably. Thus it is necessary to continuously monitor SSIs in every surgical hospital to identify the prevailing causal agents of nosocomial infections and establish systematic epidemiological control over antibacterial resistance at the local, regional and national levels. The goal of this investigation was to analyse the results of patients' surgery, to determine the incidence rate of surgical site infections (SSIs) and to identify the prevailing pathogens and resistance to antibiotics in Ukrainian hospitals.
MATERIALS AND METHODS
The investigation included 9,408 patients who underwent surgeries during 2015 (from January 2015 to December 2015) in 12 surgical hospitals in different Ukrainian regions that are similar in terms of medical equipment, laboratory facilities and number of surgeries performed. The patients' age ranged from 19 to 74. In order to determine the incidence rates of SSIs in the participating hospitals, passive search (through records from medical officers) and active identification (through epidemiological diagnostics) were used. The investigation was based on the standard definition of an SSIs as purulent discharge from a surgical wound and the identification of microorganisms in the liquid or tissue at the surgical site. The information was collected using tables for the standard criteria of SSIs diagnostics that were developed by the Centers for Disease Control and Prevention (Atlanta, USA) [23] and adopted for use in Ukraine. A wound was considered to be infected if any one of the following criteria was fulfilled: serous or nonpurulent discharge from the wound; pus discharge from the wound; serous or nonpurulent discharge from the wound with signs of inflammation (edema, redness, warmth, raised local temperature, tenderness, induration). Information from the microbiological laboratory reports and other types of medical documents was also considered. The investigation included the analysis of 1.248 strains of conditionally pathogenic microorganisms from biological material obtained from patients with clinical symptoms. The clinical sample consisted of laboratory-diagnosed SSIs that emerged no less than 48 hours after a surgery. Bacterial strains obtained for a second time from the same patients were not subject to analysis. Analysis of biological material and inter pretation of results were performed in accor dance with the approved rules for clinical ma terial selection, analysis and interpretation of results. The iden tification and antimicrobial susceptibility of the cultures were determined, using automated microbiology analyzer Vitek 2 Compact (BioMerieux, France). Susceptibility to antibiotics was determined using AST cards (BioMerieux, France). Some antimicrobial sus ceptibility test used Kirby -Bauer antibiotic testing. Interpretative criteria were those sug gested by the Clinical and Laboratory Standards Institute (CLSI) [24] . Data obtained were transferred for further analysis into computer software WHONET 5.1 (© 1989-2001, World Health Organization. All rights reserved. Freeware downloadable from http:// www.who.int/drugresistance/whonetsoftware/ en/). The analysis of statistical data was performed using Microsoft Excel. Values of p < 0.05 were considered statistically significant.
RESULTS
Data analysis demonstrated that 13.3 % (CI 95 %: 12.3-14.2 %) patients developed postoperative SSIs. Infection rates after various surgical procedures at surgical sites were observed. Table  1 shows the high infection rate in appendectomy (17.47 %), gastric, small and large bowel surgeries (18.23 %). The infection rate in orthopedic procedures (13.27 %), cholelithiasis (hepatobiliary) (14.93 %), uterus and adnexal structures (11.1 %), urinary tract and genitalia (9.37 %) and hernia (14.1 %) are comparatively lower. The infection rate in lower segment caesarean structure (LSCS) is 4.24 % and excision of dermoid cysts, lipomas 3.22 % ( Table 1) . The analyses of etiological SSIs agents showed that 54.1 % of the microorganisms obtained (675/1,248) from surgery wounds were Grampositive and 45.9 % (573/1,248) were Gramnegative (Table 2) . Patients with SSIs Staphylococcus had the highest proportion of CPM (31.3 %) followed by Enterobacteriaceae (28.9 %). The etiological role was lower for Streptococcaceae (14.7 %) and Pseudomonadaceae (P. aeruginosa) (10.1 %). The remaining 6.9 % included A. baumannii. Gramnegative organisms were mostly isolated from surgeries on bowel, urinary tract and appendix. S. aureus is the predominant organism infecting LSCS. No other organism is particularly associated with specific surgery. Prevailing causal agents of SSIs were resistant to many antimicrobial medicines used in the hos pitals. Resistant to antibiotics SSIs agents were identified among Gram-positive and Gram-ne gative microorganisms. Antibiotic susceptibility testing showed that all the strains of S. aureus resistant to penicillin. Based on antimicrobial susceptibility analysis, (Table 3) .
It is widely known that enterococci are by nature resistant to cephalosporins and can also acquire resistance to almost any class of antibiotics including penicillins, aminoglycosides, and glycopeptides. We focused on E. faecalis, the resistance of which to ceftibuten, chloramphenicol, moxifloxacin, and teicoplanin was 100 % and to cefepime and clarithromycin 96 % and 87.5 %, respectively. . In our study, the proportion of K. pneumoniae isolates resistant to carbapenems was lower than those previously reported. Imipenem-resistant isolates of K. pneumoniae showed the lowest resistance to tetracycline (19.1 %) and amikacin (35.7 %). In surgical hospitals of Ukraine 39.6 % of P. aeruginosa strains were resistant to all tested antibiotics. The most potent antimicrobials were meropenem, tobramycin, imipenem and levofloxacin. The high rates of resistance were found to erythromycin (60.3 %), rifampicin (58.2 %), tetracycline (56.8 %), azithromycin (54.5 %), amoxicillin (53.3 %), cefalexin (54.2 %), ampicillin/sulbactam (51.2 %), clarithromycin (51.0 %), and to pefloxacin (50.4 %). P. aeruginosa strains were 100 % resistant to oxacillin, ceftibuten, tetracycline, erythromycin, and laevomycetin. These strains also had a high resistance to cefotaxime (93 %), vancomycin (86.7 %), and doxycycline (81 %) (Figure 1 ). Most of antibiotic groups were not very ac tive to the strains of A. baumannii. In 2015 cep halosporin and ciprofloxacin were inactive to A. baumannii.
Amicacine and gentamycin had very low activity (30-35 % of strains), about 50 % of strains were sensitive to piperacillin-tazobactam and cefoperazon-sulbactam. Netilmicin (80 %) was of the greatest activity. Imipenem was more active than meropenem (94 % of strains vs 64 %). Among the most common agents causing SSIs, the highest resistance was among A. baumannii strains; 100 % to oxacillin, ceftibuten, kanamycin, and gentamycin. Theses strains were also highly resistant to doxycycline (85.5 %), ciprofloxacin (85 %), cefepime (74.9 %), cefuroxime (72.1 %), levofloxacin (69.6 %), cefotaxime (68.7 %), chloramphenicol (68.7 %), azithromycin (68.5 %), and amikacin (67.3 %).
DISCUSSION
Results of this investigation indicate that official statistical data fail to report the actual scale of nosocomial infection transmission in Ukrainian surgery hospitals due to the lack of reliable SSIs registration. To estimate the epidemiological situation correctly, it is necessary to assess SSIs incidence rates based on diagnostic information determined by medical officers (passive method) and epidemiological data (active method) using commonly applied standard criteria of case definition.
In accordance with state statistical reports, an average of 4.3 million surgeries are conducted annually in Ukrainian hospitals. However, only 3.200 cases of SSIs are officially registered per year (0.07 % per 100 surgeries) [6, 9] . Results of our investigation revealed a much higher SSIs incidence rate that reported in the official statistical data. The problem of postoperative wound infection is seen in both developed and developing count ries, despite introduction of meticulous antiseptic regime in surgical practice. It can occur from either an endogenous or an exogenous source. In this study, 1248 patients got infected postoperatively with the postoperative SSIs rate of 13.3 %. This is comparable with the rates reported by various authors [6-10, 25, 26] . Low infection rate in developed countries may be due to vast differences in working conditions prevailing in these countries [5, 11, 13] . The higher rates reported by some authors may be due to the inclusion of contaminated and dirty wound types and also emergency surgeries in their studies.
Results showed that 1248 strains bacteria were isolated from surgical patients during the 2015, the Gram-negative bacilli was 45.9 %, Gram-positive cocci was 54.1 %. The top five were S. aureus (27.6 %), E. coli (14.1 %), E. faecalis (13.5 %), P. aeruginosa (10.1 %), and K. pneumoniae (7.1 %).
Our results correspond to data of other investigators on prevailing species of CPM that cause SSIs in the hospitals. The distribution of various groups of microorganisms varies considerably [5] [6] [7] [8] [9] [10] [25] [26] [27] [28] [29] . This proves the necessity of carrying out microbiological monitoring in every surgery hospital. The problem of antimicrobial resistance is seen in both developed and developing countries. The prevailing causal agents of SSIs were resistant to many antimicrobial medicines used in the hospitals. Resistant to antibiotics SSIs agents were identified among Gram-positive and Gram-negative microorganisms. Antibiotic susceptibility testing showed that all the strains of S. aureus resistant to penicillin. The most active antibiotics found were linezolid, tigecycline, and mupirocin, showing growth inhibition of 100 % strains tested, followed by nitrofurantoin, trimethoprim/sulphamethoxazole, to fusidic acid, teicoplanin, fosfomycin, gentamycin, vancomycin. Susceptibility to tetracycline, rifampicin, erythromycin, and clindamycin was observed to be some lower. MRSA comprised 29.1 %, while VRSA comprised 9.3 %. Resistance E. faecalis to ceftibuten, chloramphenicol, moxifloxacin, and teicoplanin was 100 % and to cefepime 96 %. The proportion of vancomycin-resistant enterococci (VRE) was 6.9 %. 26.5 % of E. coli strains showed resistance to all tested antibiotics. The most potent antimicrobials were imipenem, tobramycin, meropenem, levofloxacin and amikacinum. The high rates of resistance were found to penicillum, lincomycin, clindamycin, ampicillin, clarithromycin, amoxicillin, and to ce fu roxime. K. pneumoniae showed the lowest resistance to amikacin and imipenem, and was moderately sensitive to cefepime, gentamicin, ceftriaxone, tobramycin, piperacillin/tazobactam, ciprofloxacin, tetracycline, ceftazidime, and aztreonam. 39.6 % of P. aeruginosa were resistant to all tested antibiotics. The most potent antimicrobials were meropenem, tobramycin, imipenem and levofloxacin. The high rates of resistance were found to penicillin, erythromycin, rifampicin, tetracycline, azithromycin, amoxicillin, cefalexin, ampicillin/sulbactam, clarithromycin, and to pefloxacin. P. aeruginosa were 100 % resistant to oxacillin, ceftibuten, tetracycline, and erythromycin. This is comparable with the rates reported by various authors [5, 6, 10, [25] [26] [27] [28] [29] [30] [31] [32] [33] . Thus, the investigation demonstrated that in the Ukrainian surgery hospitals the incidence rate of SSIs causal agents resistant to antimicrobial medicines is quite high. This poses a serious problem for curing patients from nosocomial infections. Hospital strains resistant to antimicrobial medicines were found both among Gram-positive and Gram-negative bacteria. This documents the need for systematic microbiological monitoring of main causal agents of nosocomial infections in every surgery hospital as a basic measure of epidemiological control over antimicrobial resistance. Antibiotics should be prescribed in accordance to available data on SSIs resistance. Microbiological monitoring will enable to follow the recommendations for rational antibacterial therapy of patients. Our study data have strengths and limitations. Strengths are the wide variety of antimicrobial agents included, the number of laboratories reporting data, the nationally representative geographic distribution of these institutions, and the large number of isolates. Geography is a critical consideration with surveillance of pathogens of SSIs because distribution of antimicrobial drug resistance varies within in the Ukraine [6] . 
CONCLUSIONS

